| Placebo | 0.6 mg sCT | 0.8 mg sCT | p-value |
---|---|---|---|---|
Females | n = 12 | n = 12 | n = 13 | - |
Males | n = 11 | n = 12 | n = 13 | Â |
Age (yrs) | 65.7 (4.1) | 64.5 (4.4) | 66.7 (4.1) | 0.43 |
 | 64.6 (3.7) | 65.3 (1.4) | 64.0 (4.0) | 0.58 |
YSM (yrs) | 21 (8) | 15 (6) | 17 (6) | 0.14 |
 | - | - | - | - |
Height (cm) | 168.2 (5.1) | 167.2 (7.7) | 161.9 (5.5) | 0.03 |
 | 177.8 (7.1) | 176.9 (6.1) | 175.5 (7.9) | 0.73 |
Weight (kg) | 76.4 (15.2) | 73.4 (10.3) | 78.7 (13.5) | 0.61 |
 | 89.0 (15.2) | 85.2 (9.0) | 91.9 (17.0) | 0.51 |
BMI (kg/m2) | 27.0 (5.6) | 26.4 (4.1) | 29.9 (3.9) | 0.13 |
 | 28.2 (5.1) | 27.2 (2.4) | 29.7 (4.4) | 0.32 |
KL Index | I: 7 (30%) | I: 7 (29%) | I: 9 (35%) | 0.80 |
 | II: 8 (35%) | II: 11 (46%) | II: 12 (46%) |  |
 | III: 8 (35%) | III: 6 (25%) | III: 5 (19%) |  |